O'Melveny
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Noted for its expertise in guiding leading life sciences and biotechnology companies to the Hong Kong and U.S public markets, O'Melveny is also equipped to handle M&A, IP, licensing and private equity matters. The practice is spearheaded by Beijing-based Ke Geng, reputed for out-licensing transactions, as well as leading pharmaceutical and biotechnology issuers in Hong Kong IPOs. While Ke Zhu and Portia Ku both excel in capital markets transactions.
Legal 500 Editorial commentary